
BH3-mimetic drugs prevent tumour onset in an orthotopic mouse model of hepatoblastoma
Keywords: HB; hepatoblastoma; SR; standard risk; HR; high risk; MDR; multi drug resistance; CDDP; cisplatin; BH3; Bcl-2 homology domain; High-risk hepatoblastoma; BH3-mimetic drugs; Tumour cell migration; Orthotopic HB model; TRAIL; TNF-α; ABT-737; Obatoclax; Paed